JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M112249200 on March 18, 2002

J. Biol. Chem., Vol. 277, Issue 21, 18340-18345, May 24, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/21/18340    most recent
M112249200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kristensen, C.
Right arrow Articles by Brandt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kristensen, C.
Right arrow Articles by Brandt, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Reconstitution of Insulin Receptor Binding Site from Non-binding Receptor Fragments*

Claus KristensenDagger , Asser Sloth Andersen§, Søren Østergaard§, Per Hertz Hansen§, and Jakob Brandt§

From the Departments of Dagger  Protein Expression and § Insulin Research, Novo Nordisk A/S, 2880 Bagsvaerd, Denmark

We have previously shown that a minimized insulin receptor (IR) consisting of the first 468 amino acids of the insulin receptor fused to 16 amino acids from the C terminus of the alpha -subunit (CT domain) bound insulin with nanomolar affinity (Kristensen, C., Wiberg, F. C., Schäffer, L., and Andersen, A. S. (1998) J. Biol. Chem. 273, 17780-17786). In the present study, we show that a smaller construct that has the first 308 residues fused to the CT domain also binds insulin. Insulin receptor fragments consisting of the first 468 or 308 residues did not bind insulin. However, when these fragments were mixed with a synthetic peptide corresponding to the CT domain, insulin binding was detectable. At concentrations of 10 µM CT peptide, insulin binding was fully reconstituted yielding apparent affinities of 9-11 nM. To further investigate the minimum requirement for the length of the N terminus of IR, we tested smaller receptor fragments for insulin binding in the presence of the CT peptide and found that a fragment consisting of the first 255 amino acids of IR was able to fully reconstitute the insulin binding site, yielding an apparent affinity of 11 ± 4 nM for insulin.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Insulin Research, Novo Nordisk A/S, Novo Allé 6B1.90, 2880 Bagsvaerd, Denmark. Tel.: 45-4442-3605; E-mail: jakb@novonordisk.com.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Gauguin, C. Delaine, C. L. Alvino, K. A. McNeil, J. C. Wallace, B. E. Forbes, and P. De Meyts
Alanine Scanning of a Putative Receptor Binding Surface of Insulin-like Growth Factor-I
J. Biol. Chem., July 25, 2008; 283(30): 20821 - 20829.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Lou, T. P. J. Garrett, N. M. McKern, P. A. Hoyne, V. C. Epa, J. D. Bentley, G. O. Lovrecz, L. J. Cosgrove, M. J. Frenkel, and C. W. Ward
The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity
PNAS, August 15, 2006; 103(33): 12429 - 12434.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Denley, E. R. Bonython, G. W. Booker, L. J. Cosgrove, B. E. Forbes, C. W. Ward, and J. C. Wallace
Structural Determinants for High-Affinity Binding of Insulin-Like Growth Factor II to Insulin Receptor (IR)-A, the Exon 11 Minus Isoform of the IR
Mol. Endocrinol., October 1, 2004; 18(10): 2502 - 2512.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. George, A. Johansen, M. A. Soos, H. Mortensen, S. Gammeltoft, V. Saudek, K. Siddle, L. Hansen, and S. O'Rahilly
Deletion of V335 from the L2 Domain of the Insulin Receptor Results in a Conformationally Abnormal Receptor That Is Unable to Bind Insulin and Causes Donohue's Syndrome in a Human Subject
Endocrinology, February 1, 2003; 144(2): 631 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Whittaker, H. Sorensen, V. L. Gadsboll, and J. Hinrichsen
Comparison of the Functional Insulin Binding Epitopes of the A and B Isoforms of the Insulin Receptor
J. Biol. Chem., November 27, 2002; 277(49): 47380 - 47384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.